These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 5676200)
1. Isoproterenol in massive pulmonary embolism: haemodynamic and clinical effects. McDonald IG; Hirsh J; Hale GS; Cade JF; McCarthy RA Med J Aust; 1968 Aug; 2(5):201-5. PubMed ID: 5676200 [No Abstract] [Full Text] [Related]
2. The hemodynamic response to isoproterenol in massive acute pulmonary embolism. McDonald IG; Hirsh J; Hale GS Isr J Med Sci; 1969; 5(4):839-43. PubMed ID: 5820530 [No Abstract] [Full Text] [Related]
3. Effects of acetylcholine and isoprenalin on pulmonary circulation in bronchial asthma. Dahlström G; Irnell L; Nordgren L Acta Med Scand; 1967 Dec; 182(6):755-67. PubMed ID: 6079971 [No Abstract] [Full Text] [Related]
4. Haemodynamic effects of "profadol". Sloman G; Hunt D; Hoffmann G Med J Aust; 1969 May; 1(21):1071-2. PubMed ID: 5792701 [No Abstract] [Full Text] [Related]
5. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response. Rich S; Martinez J; Lam W; Levy PS; Rosen KM Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224 [No Abstract] [Full Text] [Related]
6. Haemodynamic effects of a new anti-arrhythmic agent, mexiletine (Kö 1173) in ischaemic heart disease. Saunamäki Cardiovasc Res; 1975 Nov; 9(6):788-92. PubMed ID: 1203917 [TBL] [Abstract][Full Text] [Related]
7. Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol. Firth BG; Ratner AV; Grassman ED; Winniford MD; Nicod P; Hillis LD Am J Cardiol; 1984 Dec; 54(10):1331-6. PubMed ID: 6507308 [TBL] [Abstract][Full Text] [Related]
8. Massive pulmonary embolism: a plan of medical management. Bryant LR; Mobin-Uddin K; Utley JR; Dillon M South Med J; 1974 Jul; 67(7):825-9. PubMed ID: 4834742 [No Abstract] [Full Text] [Related]
9. [Hemodynamic effects of aminophylline in primary pulmonary hypertension]. Klein W Wien Klin Wochenschr; 1969 Sep; 81(37):651-3. PubMed ID: 5351160 [No Abstract] [Full Text] [Related]
11. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension. Prielipp RC; McLean R; Rosenthal MH; Pearl RG Crit Care Med; 1991 Jan; 19(1):60-7. PubMed ID: 1986891 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic effects of amrinone in a canine model of massive pulmonary embolism. Wolfe MW; Saad RM; Spence TH Chest; 1992 Jul; 102(1):274-8. PubMed ID: 1623767 [TBL] [Abstract][Full Text] [Related]
13. Dobutamine: a hemodynamic evaluation in pulmonary embolism shock. Jardin F; Genevray B; Brun-Ney D; Margairaz A Crit Care Med; 1985 Dec; 13(12):1009-12. PubMed ID: 4064710 [TBL] [Abstract][Full Text] [Related]
14. Effect of nitroprusside on left ventricular dynamics in mitral regurgitation. Goodman DJ; Rossen RM; Holloway EL; Alderman EL; Harrison DC Circulation; 1974 Nov; 50(5):1025-32. PubMed ID: 4430088 [No Abstract] [Full Text] [Related]
15. Haemodynamic effects of ajmaline in man. Saetre H; Ahlmark G; Ahlberg G Eur J Clin Pharmacol; 1974 Jul; 7(4):253-7. PubMed ID: 4852211 [No Abstract] [Full Text] [Related]
16. Comparison of the effects of ouabain and isoproterenol on ischemic myocardium of conscious dogs. Vatner SF; Baig H Circulation; 1978 Oct; 58(4):654-62. PubMed ID: 688576 [No Abstract] [Full Text] [Related]
17. Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine. Jewitt D; Birkhead J; Mitchell A; Dollery C Lancet; 1974 Aug; 2(7877):363-7. PubMed ID: 4136593 [No Abstract] [Full Text] [Related]
18. Nonobstructive primary myocardial disease. Hemodynamic studies in fourteen cases. Gould L; Zahir M; Calder B; Lyon AF Am J Cardiol; 1968 Oct; 22(4):523-31. PubMed ID: 5696145 [No Abstract] [Full Text] [Related]